Methyl 4,5-dibromo-3-hydroxythiophene-2-carboxylate, 98%, 1g

rel-Dimethyl (1R,2S)-cyclohex-4-ene-1,2-dicarboxylate, 97%, 10g

2-(3-acetyl-1H-indol-1-yl)propanoic acid, 95.0%, 1g

ethyl (2S,5R)-5-[(benzyloxy)amino]piperidine-2-carboxylate; oxalic acid, 97, 1g

N-Ethyl-D-glucamine>98.0%(T)250g

1-(Morpholin-2-yl)ethanone hydrochloride, 95.0%, 100mg

Methyl Glycolate>98.0%(GC)100g

3-Fluoropyridine-4-carboxamide, 97%, 250mg

(R)-4,5,6,7-Tetrahydro-benzothiazole-2,6-diamine, 97.0%, 10g

3-(1,3,2-Dioxaborinan-2-yl)pyridine, 97%, 10g

(4-(Cyclohexyl(methyl)carbamoyl)phenyl)boronic acid, 95.0%, 5g

Hexane (isomers), min. 95% (isomers), for synthesis, 2.5 L, glass packaging

BRIVANIB ALANINATE, 95%, 100mg